We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More XModerna currently has a number of mRNA-based therapeutics and vaccines in its product pipeline (Credit: rafapress/Shutterstock)